Go Back

Trilink Biotechnologies

TriLink BioTechnologies, part of Maravai LifeSciences, is a contract development and manufacturing organisation (CDMO) that assists life science leaders and innovators in overcoming challenges associated with the synthesis and scale-up of nucleic acids, NTPs, and mRNA capping analogs.

United States

TriLink BioTechnologies, a Maravai LifeSciences company, is a global provider of nucleic acid-based reagents, mRNA solutions, and contract development and manufacturing services for research, diagnostics, and therapeutic applications.

Founded in 1996, TriLink BioTechnologies specialises in the development and manufacturing of high-quality nucleic acid solutions, supporting advancements in mRNA therapeutics, gene editing, and molecular diagnostics. With expertise in oligonucleotide synthesis, mRNA capping, and custom chemistry, the company serves leading biopharmaceutical firms, academic institutions, and government agencies worldwide. Its state-of-the-art facilities enable production at research, clinical, and GMP scales, ensuring high standards of quality and regulatory compliance.

TriLink is best known for its CleanCap® technology, a widely adopted mRNA capping solution that enhances the efficiency and stability of mRNA-based vaccines and therapeutics. The company is committed to driving innovation in nucleic acid-based drug development by providing specialised reagents and scalable manufacturing solutions.

Key Products and Services:

mRNA Solutions – Including CleanCap® capping technology, custom mRNA synthesis, and IVT (in vitro transcription) reagents.
Nucleotides & Oligonucleotides – Custom and catalog nucleotides, modified bases, and high-purity oligonucleotides for research and therapeutic use.
Enzymes for IVT – High-performance RNA polymerases, including CleanScribe® and other enzymes for in vitro transcription processes.
GMP Manufacturing & CDMO Services – Custom development and scalable manufacturing for nucleic acid-based drug products.
Molecular Diagnostics – Specialised reagents and assay components for diagnostic applications.

With a strong focus on quality, innovation, and regulatory compliance, TriLink BioTechnologies continues to be a trusted partner for biopharmaceutical and life sciences companies, accelerating the development of next-generation RNA-based therapies and precision diagnostics.